- Home
- RWT vs PRTA Comparison
RWT vs PRTA Comparison
Compare RWT & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- PRTA
- Stock Information
- Founded
- RWT 1994
- PRTA 2012
- Country
- RWT United States
- PRTA Ireland
- Employees
- RWT N/A
- PRTA N/A
- Industry
- RWT Real Estate Investment Trusts
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- PRTA Health Care
- Exchange
- RWT Nasdaq
- PRTA Nasdaq
- Market Cap
- RWT 756.1M
- PRTA 809.8M
- IPO Year
- RWT 1995
- PRTA N/A
- Fundamental
- Price
- RWT $6.12
- PRTA $6.40
- Analyst Decision
- RWT Buy
- PRTA Buy
- Analyst Count
- RWT 11
- PRTA 9
- Target Price
- RWT $7.59
- PRTA $27.67
- AVG Volume (30 Days)
- RWT 1.1M
- PRTA 1.8M
- Earning Date
- RWT 07-31-2025
- PRTA 08-07-2025
- Dividend Yield
- RWT 11.76%
- PRTA N/A
- EPS Growth
- RWT 105.35
- PRTA N/A
- EPS
- RWT 0.21
- PRTA N/A
- Revenue
- RWT $241,796,000.00
- PRTA $137,935,000.00
- Revenue This Year
- RWT N/A
- PRTA N/A
- Revenue Next Year
- RWT $3.43
- PRTA $119.20
- P/E Ratio
- RWT $29.02
- PRTA N/A
- Revenue Growth
- RWT 29.65
- PRTA 54.55
- 52 Week Low
- RWT $4.68
- PRTA $4.32
- 52 Week High
- RWT $8.15
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- RWT 67.17
- PRTA 54.04
- Support Level
- RWT $5.40
- PRTA $5.96
- Resistance Level
- RWT $5.72
- PRTA $6.59
- Average True Range (ATR)
- RWT 0.15
- PRTA 0.40
- MACD
- RWT 0.06
- PRTA 0.18
- Stochastic Oscillator
- RWT 92.31
- PRTA 79.56
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).